Skip to main content
. 2019 Dec 19;25(4):e716–e721. doi: 10.1634/theoncologist.2019-0528

Table 4.

Best overall response

Best response, n (%) Total, n (%)
CR, PR, clinical benefit SD PD Not evaluable
Intended dose
5 g/m2 6 (23) 5 (19) 15 (58) 0 (0) 26 (100)
9 g/m2 13 (36) 15 (42) 7 (19) 1 (3) 36 (100)
Total 19 (31) 20 (32) 22 (35) 1 (2) 62 (100)

graphic file with name ONCO-25-e716-g006.jpg

Abbreviations: CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease.